Navigating the Complexities of Vaccine Manufacturing

Nearly every person on the planet is vulnerable to the new coronavirus, SarsCoV2. That’s why there are more than 100 projects around the world racing towards the goal of creating a safe and effective vaccine for the disease it causes, Covid-19, in the next 12 to 18 months. But this is just the first part of a long and complex process, working at a pace and scale never attempted before. In Vaccines, Money and Politics, Sandra Kanthal looks at the vast ecosystem needed to deliver a vaccination programme to the world in record time.